The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...

Intraoperative floppy iris syndrome is associated with an increased rate of severe intraoperative complications and greater ...

CEO Stephen McLeod, MD, outlines the American Academy of Ophthalmology's commitment to advocating for evidence-based, sustainable, and equitable reforms that prioritize public health and access to ...

The bio-interventional platform is for uveoscleral outflow enhancement in open-angle glaucoma patients undergoing combined ...

A retrospective study showed that the gender of the ophthalmologist influenced the amount of communication with the patient, ...

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...

Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

These offerings are designed to streamline workflows for eye care professionals and enhance patient experience.

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...